Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

"These findings reinforce the use of dapagliflozin, 10 mg, or other SGLT2 inhibitors when the therapeutic goal is to reduce ...

If you see your cardiologist and they throw out the term “heart failure,” your heart might figuratively skip a beat. The ...

Explore the latest advancements in heart disease medications, including statins, beta-blockers, ACE inhibitors, and more, for improved heart health.

The classification of drugs have been around since 1964 after Sir James Black discovered how they can assist people with ...

The company shared interim results from an ongoing Phase II trial examining its recombinant antibody fusion protein.

A comprehensive new study supports evidence of the myriad health benefits of GLP-1 medications like Ozempic and Mounjaro — ...

The message is that an early decrease in eGFR with finerenone should not lead to stopping the medication, say HF experts.

Trials and Tribulations of Cell Therapy for Heart Failure, an Update on Ongoing Trials Dec. 2, 2024 — A critical review of cell-based and cell product-based therapies for the treatment of heart ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...